Cargando…

Letter to the Editor: Bioinformatics Analysis in Downstream Genes of the mTOR Pathway to Predict Recurrence and Progression of Bladder Cancer

Detalles Bibliográficos
Autores principales:	Li, Chenyu, Liu, Hang, Xu, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2017
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760816/ https://www.ncbi.nlm.nih.gov/pubmed/29318798 http://dx.doi.org/10.3346/jkms.2018.33.e31

Ejemplares similares

The Author's Response: Bioinformatics Analysis in Downstream Genes of the mTOR Pathway to Predict Recurrence and Progression of Bladder Cancer
por: Yoo, Chang-Hyuk
Publicado: (2017)

Identification of Downstream Genes of the mTOR Pathway that Predict Recurrence and Progression in Non-Muscle Invasive High-Grade Urothelial Carcinoma of the Bladder
por: Jin, Subin, et al.
Publicado: (2017)

Role of the mTOR Pathway in the Progression and Recurrence of Bladder Cancer: An Immunohistochemical Tissue Microarray Study
por: Park, Se Jun, et al.
Publicado: (2011)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Reversing autism by targeting downstream mTOR signaling
por: Wang, Hansen, et al.
Publicado: (2013)

Letter to the Editor
por: Dharmadhikari, Ashwin S., et al.
Publicado: (2011)

Letter to Editor
por: Şahan, Ekrem, et al.
Publicado: (2017)

Letter to the Editor
por: Goldsborough, Sarah
Publicado: (2018)

Letter to Editor
por: Saks, Michael J.
Publicado: (2021)

Letter to Editor
por: Ditrich, Hans
Publicado: (2021)

Letter to the Editor
por: Narayan, Ishir
Publicado: (2023)

Signaling Pathways Leading to mTOR Activation Downstream Cytokine Receptors in Lymphocytes in Health and Disease
por: Fallone, Lucie, et al.
Publicado: (2023)

Interaction of YAP1 and mTOR promotes bladder cancer progression
por: Xu, Mingxi, et al.
Publicado: (2019)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Reply to letter to the editor
por: Kvasnovsky, Charlotte L., et al.
Publicado: (2020)

Letter to the editor: Reply
por: Shim, Jung-Woo, et al.
Publicado: (2021)

Response to Letter to the Editor
por: Mondal, Monidipa, et al.
Publicado: (2021)

Response to the letter to the editor
por: Olry de Labry Lima, Antonio, et al.
Publicado: (2021)

Response to letter to the editor
por: Sridharan, Aadhavi, et al.
Publicado: (2022)

Response to Letter to the Editor
por: Beijer, Elise, et al.
Publicado: (2022)

Response to Letter to the Editor
por: Adeniji, Folashayo, et al.
Publicado: (2023)

Dual Target of EGFR and mTOR Suppresses Triple-Negative Breast Cancer Cell Growth by Regulating the Phosphorylation of mTOR Downstream Proteins
por: Ma, Jing, et al.
Publicado: (2023)

Response to Letter to the Editor: Secondary ganglioside G(M2) accumulation in mucopolysaccharidoses
por: Derrick-Roberts, Ainslie L.K.
Publicado: (2021)

Letter to the Editor: Comment on Predatory Journals
por: Jawad, Fatema
Publicado: (2017)

Making life simple—Letter to the Editor
por: Artemiou, Panagiotis
Publicado: (2017)

Authors’ reply to Hansel’s letter to the editor
por: Kotani, Yuki, et al.
Publicado: (2023)

Letter to the Editor: Supporting the Sick and the Vulnerable
por: del Castillo, Fides A.
Publicado: (2023)

mTOR Pathways in Cancer and Autophagy
por: Paquette, Mathieu, et al.
Publicado: (2018)

The Translational Regulation in mTOR Pathway
por: Yang, Miaomiao, et al.
Publicado: (2022)

Letter to the Editor: Publication Activity of Scientific Authors
por: Joob, Beuy, et al.
Publicado: (2016)

Letter to the Editor: COVID-19 ‘Solutions’ in Bangladesh
por: Al-Zaman, Md. Sayeed
Publicado: (2021)

Letter to the Editor in Response to Zhou et al
por: Troth, Sean, et al.
Publicado: (2021)

Letter to Editor-response: placebo response rates
por: Gyawali, Bishal
Publicado: (2023)

Response to: Kumar N, Ahmed M. Letter to the editor in response to Komen et al. 2021
por: Komen, Joris J, et al.
Publicado: (2021)

Sirt3 Pharmacologically Promotes Insulin Sensitivity through PI3/AKT/mTOR and Their Downstream Pathway in Adipocytes
por: Lee, Alexandra Yatine, et al.
Publicado: (2022)

Role of mTOR Downstream Effector Signaling Molecules in Francisella Tularensis Internalization by Murine Macrophages
por: Edwards, Michael W., et al.
Publicado: (2013)

IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer
por: De Martino, Maria Cristina, et al.
Publicado: (2019)

α-Enolase Lies Downstream of mTOR/HIF1α and Promotes Thyroid Carcinoma Progression by Regulating CST1
por: Liu, Yang, et al.
Publicado: (2021)

Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy
por: Huan, Jianya, et al.
Publicado: (2022)

Letter to the Editor: Presence of Evolutionary Pressures or Genotyping Error
por: Saadat, Mostafa
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_u8kq4lteb7npj1j0qt0m26dd9n